Literature DB >> 33734411

Assessment of Concordance and Discordance Among Clinical Studies Posted as Preprints and Subsequently Published in High-Impact Journals.

Xiaoting Shi1, Joseph S Ross2, Nishita Amancharla3, Joshua D Niforatos4, Harlan M Krumholz5, Joshua D Wallach1.   

Abstract

Entities:  

Year:  2021        PMID： 33734411      PMCID： PMC7974637          DOI： 10.1001/jamanetworkopen.2021.2110

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  5 in total

1.  Submissions and Downloads of Preprints in the First Year of medRxiv.

Authors:  Harlan M Krumholz; Theodora Bloom; Richard Sever; Claire Rawlinson; John R Inglis; Joseph S Ross
Journal:  JAMA       Date:  2020-11-10       Impact factor: 56.272

2.  Preprints Involving Medical Research-Do the Benefits Outweigh the Challenges?

Authors:  Annette Flanagin; Phil B Fontanarosa; Howard Bauchner
Journal:  JAMA       Date:  2020-11-10       Impact factor: 56.272

3.  Reporting of results in ClinicalTrials.gov and high-impact journals.

Authors:  Jessica E Becker; Harlan M Krumholz; Gal Ben-Josef; Joseph S Ross
Journal:  JAMA       Date:  2014-03-12       Impact factor: 56.272

4.  Medical Preprints-A Debate Worth Having.

Authors:  David M Maslove
Journal:  JAMA       Date:  2018-02-06       Impact factor: 56.272

5.  Assessment of Preprint Policies of Top-Ranked Clinical Journals.

Authors:  Dorothy S Massey; Michelle A Opare; Joshua D Wallach; Joseph S Ross; Harlan M Krumholz
Journal:  JAMA Netw Open       Date:  2020-07-01
  5 in total
  2 in total

1.  Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.

Authors:  Jean-Francois Gehanno; Julien Grosjean; Stefan J Darmoni; Laetitia Rollin
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

2.  Transparency and reporting characteristics of COVID-19 randomized controlled trials.

Authors:  Philipp Kapp; Laura Esmail; Lina Ghosn; Philippe Ravaud; Isabelle Boutron
Journal:  BMC Med       Date:  2022-09-26       Impact factor: 11.150
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.